PlainRecalls
FDA Drug Low Class III Terminated

Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)

Reported: January 22, 2020 Initiated: January 10, 2020 #D-0790-2020

Product Description

Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)

Reason for Recall

CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.

Details

Units Affected
34,080 boxes (3 wallets per carton, 80 cartons per box)
Distribution
Distributed nationwide in the US
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet). Recalled by Lupin Pharmaceuticals Inc.. Units affected: 34,080 boxes (3 wallets per carton, 80 cartons per box).
Why was this product recalled?
CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2020. Severity: Low. Recall number: D-0790-2020.